Mettler Toledo (MTD) EV/EBITDA Multiple

Graphic logo of Mettler-Toledo International Inc. (MTD)

The EV/EBITDA multiple, adjusted for capital structure, reflects market expectations, where 27.30 indicates the level of this metric for Mettler-Toledo International (MTD). Investor optimism is bolstered by the implementation of green standards and production energy efficiency. High profitability enables the company to attract leading mechanical engineers on favorable terms. The diversification of high-precision instrument supplies for medicine and industry guarantees the stability of the business.

MTD (Mettler-Toledo International Inc.) Business Value to Operating Income Before Depreciation history from 11/23/2025 to 11/17/2026

MTD (Mettler Toledo): analytical breakdowns and indicator data

- current price and projected stock value:
Fundamental company valuation:mt.com MTD
Product sample of mt.com

For Mettler-Toledo International (MTD), a leader in the precision equipment sector, the business's current EV/EBITDA multiple serves as an indicator of fair value. This metric compares the total enterprise value, including net debt, with its operating profit before depreciation and amortization. This allows for an assessment of laboratory automation efficiency without distortions from tax regimes. The downward trend on this chart signals that the asset is undervalued amid stabilizing demand in the pharmaceutical industry.

Analysis of competing companies

EV/EBITDA Multiple ABT (abbott.com)|Total Company Value to Operating Income Before Depreciation Ratio Thermo Fisher Scientific (TMO)|GE HealthCare Technologies Inc. - EV/EBITDA Multiple|Waters Corp. (WAT) - Enterprise Value to EBITDA Ratio|TECH: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Bruker Corporation|Enterprise Value to EBITDA Ratio AZTA|VREX: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Semler Scientific Inc (SMLR)|Enterprise Value to EBITDA Ratio Butterfly Network BFLY|EV/EBITDA Multiple MLAB (mesalabs.com)|QSI: Enterprise Value to Operating Income Before Depreciation|Nano-X - EV/EBITDA Multiple|QTRX (Quanterix Corporation) - Enterprise Value to Operating Income Before Depreciation|MASS: EV/EBITDA Multiple|CapsoVision Medical (CV) - EV/EBITDA Multiple|MXCT (MaxCyte Inc) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Rapid Micro Biosystems (RPID)|EV/EBITDA Multiple SEER|EV/EBITDA Multiple hyperfine.io (HYPR)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization FONAR FONR|Business Value to Operating Income Before Depreciation DXR|MDAI: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation VIVS (Organovo Holdings, Inc.)|ACON: EV/EBITDA Multiple|Company Value to EBITDA Akoya (AKYA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization thermogenesis.com|TLIS - Enterprise Value to EBITDA Multiple|Enterprise Value to EBITDA Ratio TTOO (T2 Biosystems Inc.)